Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2018-05-14 Director's Dealing
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
高级管理人员减持股份结果公告
Director's Dealing Classification · 100% confidence The document is titled as an announcement regarding the results of shareholding reduction by a senior management person (Vice President Wang Yongsheng) of the company. It details the number of shares held before and after the reduction, the reduction plan implementation period, and the completion status of the reduction plan. There is no financial data, earnings, or report content. The document is a formal announcement of a director's dealing in shares (insider share transactions). The document length is short (1143 characters), and it is clearly a notification of share transactions by a senior executive, matching the definition of Director's Dealing (DIRS).
2018-05-14 Chinese
2017年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "2017 年年度股东大会会议资料" which translates to "2017 Annual General Meeting (AGM) Meeting Materials". It contains detailed agenda items for the AGM, including reports from the board of directors, supervisory board, annual report summary, financial report, profit distribution plan, independent directors' reports, and other meeting procedures. The content is clearly materials prepared and shared for the Annual General Meeting of shareholders. It is not the annual report itself but the meeting materials for the AGM where such reports are presented and discussed. The document length is substantial (15,000 characters), indicating it is not a brief announcement but the actual meeting materials. Therefore, the appropriate classification is AGM Information (AGM-R).
2018-05-11 Chinese
关于召开2017年年度股东大会的提示性公告
AGM Information Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2017 Annual General Meeting (AGM) of 金宇生物技术股份有限公司, including the date, voting methods, agenda items, and procedural details. It includes information about the meeting logistics, voting system, and proxy authorization form. The document does not contain the actual annual report or financial statements but rather serves as a notice and instructions for the upcoming AGM. The document length is under 5,000 characters and is clearly an announcement for the AGM rather than the report itself. Therefore, it fits the category of AGM Information (AGM-R).
2018-05-11 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the progress of using idle self-owned funds for cash management investments. It details specific investment contracts, amounts, expected yields, and risk control measures. The document is relatively short (3053 characters) and focuses on an update about financing activities related to cash management, not a full financial report or earnings release. There is no indication of it being an annual or interim report, audit report, or earnings release. It is not a regulatory certification or voting result. The content fits best with a Capital/Financing Update as it informs about the company's financing activities and investment of idle funds.
2018-05-09 Chinese
关于第一大股东补充质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the supplementary pledge of shares by the company's largest shareholder. It details the number of shares pledged, the pledge period, and the shareholder's current shareholding and pledge status. There is no financial report, earnings data, or management discussion. The content is about a shareholder's share pledge, which relates to capital structure but is specifically about share pledging by a major shareholder. This fits best under the category of Major Shareholding Notification (MRQ), as it involves disclosure of significant share ownership and pledge changes by a major shareholder. The document is short and focused on this specific event, not a full report or announcement of a report publication.
2018-05-02 Chinese
关于为子公司银行授信提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 金宇生物技术股份有限公司 regarding providing guarantees for bank credit to its wholly-owned subsidiaries. It details the guarantee amount, the subsidiaries involved, the board and independent directors' opinions, and the legal compliance of the guarantee. There are no financial statements or comprehensive financial performance data presented. The document is a formal announcement of a corporate action related to financing support but does not report on financial results or capital changes such as new share issues or repurchases. It fits best under Capital/Financing Update (CAP) as it concerns financing activities (bank credit guarantees) and capital structure implications.
2018-04-27 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.